Follow the NxStage Medical, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 12 February 2016 (Levée d'options). Among the most active insiders: Turk Joseph E Jr. Every trade is free.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NxStage Medical, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.